A series of broad spectrum antiviral peptides and composition including therapeutically effective amounts of the antiviral peptides along with a pharmaceutically acceptable carrier were developed. The antiviral compositions show a strong broad spectrum antiviral effect without resulting to viral resistance. These antiviral peptides are effective in treating diseases caused by viral infections, particularly respiratory viruses.
Viral infection annually still causes millions of deaths globally. Taking Influenza virus as an example, annually causes over 3 to 5 million cases of severe illness with about 0.25 million deaths globally. In addition, resistance was found in most of current anti-viral drugs so it is essential to develop a new broad spectrum anti-viral drug.
Founded in 1911, The University of Hong Kong (HKU) is the first and oldest institution of higher education in Hong Kong. For over a century, the University has dedicated itself to creating knowledge, providing education, and serving society. Today, HKU has an established worldwide reputation for being a research-led comprehensive University with ten Faculties and a strong commitment to intellectual freedom, liberty and diversity. HKU has a proud record of academic recognition in researches through honours and awards received from both local and international bodies.